Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	11/3/2000 5:11:35 AM
From: nigel bates	Read Replies (2) of 4974

Nov. 2 /PRNewswire/ -- Corvas International, Inc. (Nasdaq: CVAS - news) today announced the pricing of a public offering of 5,000,000 shares of its common stock at a price of $20.00 per share. All of the 5,000,000 shares of common stock included in the offering are being sold by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares to cover over-allotments, if any....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next